ARTICLE | Financial News

Lightstone closes $250M fund

September 20, 2017 8:06 PM UTC

Lightstone Ventures closed Lightstone Ventures II at $250 million. Lightstone said the fund will invest $15-$20 million in each of about 15 early stage biotech and medical device companies. The fund has invested in one undisclosed company and participated in Tuesday's $30 million series A round for Disarm Therapeutics Inc. (Cambridge, Mass.) (see BioCentury Extra, Sept. 19)...

BCIQ Company Profiles

Disarm Therapeutics Inc.